Baxter International (BAX) Competitors $24.12 +0.14 (+0.58%) As of 12:27 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BAX vs. AMN, DVA, RMD, DXCM, STE, PODD, HOLX, MASI, GMED, and TFXShould you be buying Baxter International stock or one of its competitors? The main competitors of Baxter International include AMN Healthcare Services (AMN), DaVita (DVA), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), Masimo (MASI), Globus Medical (GMED), and Teleflex (TFX). These companies are all part of the "medical" sector. Baxter International vs. Its Competitors AMN Healthcare Services DaVita ResMed DexCom STERIS Insulet Hologic Masimo Globus Medical Teleflex Baxter International (NYSE:BAX) and AMN Healthcare Services (NYSE:AMN) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership. Is BAX or AMN more profitable? Baxter International has a net margin of -1.42% compared to AMN Healthcare Services' net margin of -10.75%. Baxter International's return on equity of 16.96% beat AMN Healthcare Services' return on equity.Company Net Margins Return on Equity Return on Assets Baxter International-1.42% 16.96% 5.24% AMN Healthcare Services -10.75%11.09%3.34% Which has preferable valuation and earnings, BAX or AMN? AMN Healthcare Services has lower revenue, but higher earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBaxter International$10.64B1.17-$649M-$0.30-80.51AMN Healthcare Services$2.98B0.24-$146.98M-$7.77-2.43 Do insiders & institutionals hold more shares of BAX or AMN? 90.2% of Baxter International shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 0.2% of Baxter International shares are owned by insiders. Comparatively, 0.9% of AMN Healthcare Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media prefer BAX or AMN? In the previous week, AMN Healthcare Services had 16 more articles in the media than Baxter International. MarketBeat recorded 21 mentions for AMN Healthcare Services and 5 mentions for Baxter International. AMN Healthcare Services' average media sentiment score of 0.49 beat Baxter International's score of 0.18 indicating that AMN Healthcare Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baxter International 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral AMN Healthcare Services 5 Very Positive mention(s) 5 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral Which has more volatility and risk, BAX or AMN? Baxter International has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500. Comparatively, AMN Healthcare Services has a beta of 0.1, indicating that its share price is 90% less volatile than the S&P 500. Do analysts prefer BAX or AMN? Baxter International currently has a consensus target price of $30.11, indicating a potential upside of 24.67%. AMN Healthcare Services has a consensus target price of $28.25, indicating a potential upside of 49.77%. Given AMN Healthcare Services' stronger consensus rating and higher possible upside, analysts plainly believe AMN Healthcare Services is more favorable than Baxter International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baxter International 1 Sell rating(s) 6 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.20AMN Healthcare Services 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.25 SummaryAMN Healthcare Services beats Baxter International on 8 of the 15 factors compared between the two stocks. Get Baxter International News Delivered to You Automatically Sign up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BAX vs. The Competition Export to ExcelMetricBaxter InternationalMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$12.41B$10.58B$5.61B$20.90BDividend Yield2.90%2.00%4.64%3.65%P/E Ratio-80.5120.2930.2028.69Price / Sales1.1724.32462.1959.89Price / Cash4.9423.7337.7222.93Price / Book1.703.088.485.42Net Income-$649M$211.77M$3.26B$994.60M7 Day Performance7.22%7.88%3.14%2.28%1 Month Performance-15.99%8.77%5.64%1.24%1 Year Performance-30.11%-6.88%42.56%15.57% Baxter International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BAXBaxter International4.8192 of 5 stars$24.15+0.7%$30.11+24.7%-35.1%$12.41B$10.64B-80.5138,000AMNAMN Healthcare Services4.2057 of 5 stars$17.43-2.4%$32.08+84.1%-67.2%$667.03M$2.98B-4.022,968News CoverageEarnings ReportAnalyst ForecastDVADaVita4.5408 of 5 stars$139.67+0.9%$167.40+19.9%-8.0%$10.54B$12.97B13.8476,000News CoverageRMDResMed4.6332 of 5 stars$291.30+4.3%$274.83-5.7%+32.1%$42.71B$5.15B30.639,980Positive NewsAnalyst DowngradeInsider TradeDXCMDexCom4.9033 of 5 stars$76.25-3.8%$99.89+31.0%+12.5%$29.90B$4.03B52.9510,300Analyst DowngradeSTESTERIS4.7496 of 5 stars$228.62+0.8%$270.33+18.2%+4.2%$22.49B$5.46B36.8717,787Earnings ReportInsider TradePODDInsulet4.3507 of 5 stars$287.77+1.0%$321.00+11.5%+64.7%$20.25B$2.20B51.763,900Positive NewsEarnings ReportAnalyst RevisionHOLXHologic4.798 of 5 stars$67.91+1.1%$76.42+12.5%-16.9%$15.10B$4.03B28.187,063MASIMasimo4.3555 of 5 stars$161.27+4.8%$191.60+18.8%+17.5%$8.74B$2.09B-17.595,600GMEDGlobus Medical4.9539 of 5 stars$53.64+1.9%$90.09+68.0%-15.4%$7.26B$2.52B40.035,300News CoverageEarnings ReportAnalyst RevisionTFXTeleflex4.5882 of 5 stars$116.24+0.3%$141.57+21.8%-47.6%$5.14B$3.05B27.3514,100Positive News Related Companies and Tools Related Companies AMN Competitors DVA Competitors RMD Competitors DXCM Competitors STE Competitors PODD Competitors HOLX Competitors MASI Competitors GMED Competitors TFX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BAX) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baxter International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Baxter International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.